1933 Industries Inc (TGIFF)
0.0125
0.00 (0.00%)
USD |
OTCM |
Apr 24, 12:52
1933 Industries Revenue (TTM): 14.27M for Jan. 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
January 31, 2024 | 14.27M |
October 31, 2023 | 13.95M |
July 31, 2023 | 13.62M |
April 30, 2023 | 11.94M |
January 31, 2023 | 12.30M |
October 31, 2022 | 11.64M |
July 31, 2022 | 9.874M |
April 30, 2022 | 9.893M |
January 31, 2022 | 9.211M |
October 31, 2021 | 9.326M |
July 31, 2021 | 9.397M |
April 30, 2021 | 9.100M |
January 31, 2021 | 8.284M |
October 31, 2020 | 8.022M |
July 31, 2020 | 8.921M |
April 30, 2020 | 11.12M |
January 31, 2020 | 12.72M |
October 31, 2019 | 13.10M |
July 31, 2019 | 13.64M |
April 30, 2019 | 12.63M |
January 31, 2019 | 11.77M |
October 31, 2018 | 11.34M |
July 31, 2018 | 9.834M |
April 30, 2018 | 7.679M |
January 31, 2018 |
Date | Value |
---|---|
October 31, 2017 | |
July 31, 2017 | |
April 30, 2017 | |
January 31, 2017 | |
October 31, 2016 | |
July 31, 2016 | |
April 30, 2016 | |
January 31, 2016 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.022M
Minimum
Oct 2020
14.27M
Maximum
Jan 2024
11.15M
Average
11.38M
Median
Revenue (TTM) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 175.51M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.386M |
Xenon Pharmaceuticals Inc | -- |